电阻抗谱在多痣及大型获得性痣患者中的诊断性能
本研究对非典型痣综合征患者进行横断面研究,评估电阻抗谱(EIS)对临床稳定痣的评分及重测信度。结果显示89.2%的大型痣、88.3%的非典型外观痣和65.0%的小痣EIS评分≥4(假阳性),重测Bland-Altman 95%CI为±2.85,EIS与CASH皮肤镜评分正相关(95%CI 0.11-0.25,P<.001)。结论认为EIS不能 indiscriminately 用于稳定痣的筛查,短期随访中EIS评分变化<3可能无临床意义。
要点
- 非典型痣综合征患者中,多数稳定痣EIS评分≥4,假阳性率高。
- EIS重测信度中等,Bland-Altman 95%CI为±2.85。
- 短期随访中EIS评分变化<3可能无临床意义。
核心结论
- EIS不能 indiscriminately 用于非典型痣综合征患者稳定痣的筛查评估。
- 短期随访中EIS评分变化<3可能不代表临床显著变化。
研究设计与样本
- 横断面研究,纳入年龄≥30岁、痣数量≥100个、至少3个直径>5mm的大型获得性痣且3年前有全身照片的患者。
- 对选定的临床稳定痣在初诊和2-6周随访时进行EIS评分。
主要发现
- 89.2%的大型痣、88.3%的非典型外观痣和65.0%的小痣EIS评分≥4(假阳性)。
- 重测信度Bland-Altman 95%CI为±2.85。
- EIS与CASH皮肤镜评分正相关(95%CI 0.11-0.25,P<.001)。
关键数值与推荐
- EIS评分≥4定义为假阳性阈值。
- EIS与CASH评分关联的95%CI为0.11-0.25,P<.001。
临床怎么用
- 在非典型痣综合征患者中,不应单独依赖EIS筛查稳定痣。
- 短期随访中EIS评分变化<3可能无需过度解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Patients with atypical mole syndrome may benefit from screening methods that enable early melanoma detection and prevent unnecessary biopsies. Electrical impedance spectroscopy (EIS)'s utility in this patient population has not previously been reported. Therefore, we conducted a cross-sectional study of nevi in patients with atypical mole syndrome to characterize the EIS scores of clinically stable nevi in this patient population and to evaluate the test-retest reliability of EIS. EIS scores of selected clinically stable nevi were taken at an initial visit and 2-6-week follow-up visit. Patients invited for participation were aged ≥30 years, had ≥100 nevi, had at least 3 large acquired nevi >5 mm in diameter, and had baseline total body photographs obtained ≥3 years prior to initial visit. A total of 89.2% of large, 88.3% of atypical-appearing, and 65.0% of small nevi had false-positive EIS scores ≥4. Modest agreement was observed in test-retest reliability at 2-6-week follow-up with Bland-Altman 95% confidence interval of ±2.85. EIS and CASH (color, architecture, symmetry, and homogeneity) dermoscopy scores were positively associated (95% confidence interval = 0.11-0.25, P < .001). We conclude that EIS cannot indiscriminately be used in the screening evaluation of stable nevi in patients with atypical mole syndrome ; changes in EIS score <3 may not represent clinically significant change during short-term follow-up of stable nevi.
引用
- Nazir ZH, Manci R, Nanda JK, et al. Diagnostic performance of electrical impedance spectroscopy in patients with multiple nevi and large acquired nevi. J Invest Dermatol. 2025. PMID: 41253252. doi:10.1016/j.jid.2025.10.611
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。